دورية أكاديمية
449TiP Evaluation of regorafenib treatment PERSOnalization based on therapeutic drug monitoring in patients with metastatic colorectal cancer (mCRC): RePERSO study.
| العنوان: | 449TiP Evaluation of regorafenib treatment PERSOnalization based on therapeutic drug monitoring in patients with metastatic colorectal cancer (mCRC): RePERSO study. |
|---|---|
| المؤلفون: | Tron, C.1 (AUTHOR), Lemaitre, F.1 (AUTHOR), Locher, C.1 (AUTHOR), Lecomte, T.2 (AUTHOR), Tournigand, C.3 (AUTHOR), Bouhier Leporrier, K.4 (AUTHOR), Le Sourd, S.5 (AUTHOR), Metges, J-P.6 (AUTHOR), Tougeron, D.7 (AUTHOR), Di Fiore, F.8 (AUTHOR), Hervé, C.9 (AUTHOR), Heran, M.10 (AUTHOR), Touchefeu, Y.11 (AUTHOR), Rousseau, B.J-C.12 (AUTHOR), Hulin, A.13 (AUTHOR), Lievre, A.14 (AUTHOR) |
| المصدر: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS739-S740. 2p. |
| مصطلحات موضوعية: | *DRUG monitoring, *PATIENT monitoring, *COLORECTAL cancer, *METASTASIS, *REGORAFENIB |
| قاعدة البيانات: | Academic Search Index |
Full Text Finder | تدمد: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2022.07.1870 |